Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Has sapropterin reduced patient's symptom frequency?How do protein sources impact lipitor's effectiveness?How did simvastatin use impact the patient's liver health?Are there any alternatives to lipitor for yoga practitioners?How did sapropterin's discovery impact treatment timelines?
See the DrugPatentWatch profile for lipitor
Lipitor primarily affects the protein HMG‑CoA reductase (3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase), an enzyme in the liver that plays a key role in producing cholesterol. By inhibiting this enzyme, Lipitor lowers cholesterol levels in the body [1].
When HMG‑CoA reductase activity drops, the liver makes less cholesterol. The liver then increases the production of LDL receptors on its cell surface, which pulls LDL (“bad cholesterol”) out of the bloodstream via LDL uptake. This process involves LDL receptor proteins, but the primary direct target of Lipitor is HMG‑CoA reductase [1].
Lipitor’s main effect is on a liver enzyme (HMG‑CoA reductase), not on a circulating blood protein. Its cholesterol-lowering effect occurs because lowering cholesterol production prompts the liver to change how much LDL receptor protein it displays to clear LDL from the blood [1].
Other Questions About Lipitor :